Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-16
1999-11-02
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514556, A61K 31385, A61K 31205
Patent
active
059771623
ABSTRACT:
A nutritional supplement for enhancing mitochondrial function in cells includes 10-1000 mg of alpha-lipoic acid, 10-1000 mg acetyl-L-carnitine, 15-360 mg coenzyme Q-10, and 15-360 mg glutathione. The composition may further comprise a carrier for these components such as a liquid or tablet for oral ingestion on a daily basis.
REFERENCES:
patent: 4135790 (1979-01-01), Takahashi et al.
patent: 4193670 (1980-03-01), Giglia et al.
patent: 4293194 (1981-10-01), Takahashi
patent: 4313648 (1982-02-01), Yano et al.
patent: 4325611 (1982-04-01), Huggins et al.
patent: 4350414 (1982-09-01), Takahashi et al.
patent: 4585312 (1986-04-01), Ishiwata et al.
patent: 4664934 (1987-05-01), Ito et al.
patent: 4775227 (1988-10-01), Silver
patent: 4824221 (1989-04-01), Endo et al.
patent: 4935934 (1990-06-01), Ferrand et al.
patent: 4962504 (1990-10-01), Aubert et al.
patent: 5011582 (1991-04-01), Oshikawa et al.
patent: 5124822 (1992-06-01), Becker et al.
patent: 5140604 (1992-08-01), Alablanche et al.
patent: 5148306 (1992-09-01), Yamada et al.
patent: 5188902 (1993-02-01), Lin
patent: 5202788 (1993-04-01), Weppner
Ames, B.N. Dietary Carcinogens and Anticarcinogens. Oxygen Radicals and Degenerative Diseases. Science. 221(4617):1256-64, Sep. 23, 1983.
Bast A and Haenen GR. Interplay between Lipoic Acid and Glutathione in the Protection Against Microsomal Lipid Peroxidation. Biochimica et Biophysica Acta. 963(3):558-61. Dec. 16, 1988.
Devasagayam TP, Subramanian M, Pradhan DS, Sies H. Prevention of Singlet Oxygen-Induced DNA Damage by Lipoate. Chemico-Biological Interactions. 86(1):79-92. Jan. 1993.
Dimpfel W, Spuler M, Pierau FK, Ulrich H. Thiotic Acid Induces Dose-Dependent Sprouting of Neurites in Cultured Rat Neuroblastoma Cells. Dev. Pharmacol. Ther. 14(3):193-99. 1990.
Fariello RG et al, Systemic Acetyl-L-Carnitine Elevates Nigral Levels of Glutathione and GABA. Life Sci. 43:289-292. 1988.
Fujii T, Kuraishi M and Satoh M. Specific Binding Sites for Bifemelane in the Hippocampus of the Guinea Pig, Relevant to its Pharmacological Actions. Neuropharmacology 30:1291-1995. 1991.
Gadaleta MN, Petruzella V, Daddabbo L, Olivieri C, Fracasso F, Loguercio Polosa P, Cantatore P. Mitochondrial DNA Transcription and Translation in Aged Rat. Effect of Acetyl-L-Carnitine. Ann. NY Acad. Sci. 717:150-160. 1994.
Gersdorff M, Franceschi D. Interet du Piracetam Dans le Traitement de la Surdite Brusque Idiopathique. Ann. Oto-Laryng. (Paris) 103:283-285. 1986.
Giurgea C and Mouravieff-Lesuisse F. Pharmacological Studies on an Elementary Model of Learning--The Fixation of an Experience at Spinal Level: Part I: Pharmacological Reactivity of the Spinal Cord Fixation Time. Arch. int. Pharmacodyn. 191:279-291. (1971).
Harman D. Nutritional Implications of the Free-Radical Theory of Aging. Journal of the American College of Nutrition. 1(1):27-34. 1982.
Harman D. Free Radical Theory of Aging: Effect of Free Radical Reaction Inhibitors on the Mortality Rate of Male LAF Mice. Journal of Gerontology. 23(4):476-82. Oct. 1968.
Harman D. The Aging Process. Proceedings of the National Academy of Sciences of the USA. 78(11):7124-8. Nov. 1981.
Heidrick ML, Hendricks LC, Cook DE. Effect of Dietary 2-Mercaptoethanol on the Life Span, Immune System, Tumor Incidence and Lipid Peroxidation Damage in Spleen Lymphocytes of Aging BC3F.sub.1 Mice. Mechanisms of Aging & Development. 27(3):341-58. Oct. 31, 1984.
Herrmann WM and Stephan K. Efficacy and Clinical Relevance of Cognition Enhancers. Alzheimer Disease and Associated Disorders 5:S7-S12. 1991.
Imperato A, Ramacci MT, Angelucci L. Acetyl-L-Carnitine Enhances Acetylcholine Release in the Striatum and Hippocampus of Awake Freely Moving Rats. Neurosci. Lett. 107:251-255. 1989.
Kabes J, Erban L, Hanzlicek L and Skondia V. Biological Correlates of Piracetam Clinical Effects in Psychotic Patients. J. Int Med. Res. 7:277-283. 1979.
Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, Packer L. Dihydrolipoic Acid--A Universal Antioxidant Both in the Membrane and in the Aqueous Phase. Reduction of Peroxyl, Ascorbyl and Chromanoxyl Radicals. Biochem. Pharmacol. 44:1637-1649. 1992.
Markowska AL, Olton DS. Dietary Acetyl-L-Carnitine Improves Spatial Behaviour of Old Rats. Int. J. Clin. Pharmacol Res. 10:65-68. 1990.
Orlando G, Milano S, Ramacci MT and Angelucci L. Effect of Acetyl-L-Carnitine Chronic Treatment on Discrimination Models in Aged Rats. Physiology & Behavior, 44:769-773. 1988.
Paradies G, Ruggiero FM, Pestrosillo G, Gadaleta MN, Quagliariello E. Effect of Aging and Acetyl-L-Carnitine on the Activity of Cytochrome Oxidase and Adenine Nucleotide Translocase in Rat Heart Mitochondria. FEBS Lett. 350:213-215. 1994.
Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L and Senin U. Acetyl-L-Carnitine in the Treatment of Mildly Demented Elderly Patients. Int. J. Clin Pharm. Res. X(1/2):75-79. 1990.
Sapolsky R, Armanini M, Packan D, Tombaugh G. Stress and Glucocorticoids in Aging. Endocrinol. Metab. Clin. North Am. 16(4):965-980. 1987.
Scholich H, Murphy ME, Sies H. Antioxidant Activity of Dihydrolipoate Against Microsomal Lipid Peroxidatin and Its Dependence on Alpha-Tocopherol. Biochimica et Biophysica Acta. 1001(3):256-61. Feb. 20, 1989.
Serbinova E, Khwaja S, Reznick AZ, Packer L. Thioctic Acid Protects Against Ischemia--Reperfusion Injury in the Isolated Perfused Langendorff Heart. Free Radic. Res. Comm. 17(1):49-58, 1992.
Suzuki YJ, Tsuchiya M, Packer L. Lipoate Prevents Glucose-Induced Protein Modifications. Free Radical Res. Comm. 17(3):211-217. 1992.
Suzuki YJ, Tsuchiya M, Parker L. Thioctic Acid and Dihydrolipoic Acid are Novel Antioxidants which Interact with Reactive Oxygen Species. Free Radc. Res. Comm. 15:255-263. 1991.
Tolmasoff JM, Ono T, Cutler RG. Superoxidase Dismutase: Correlation with Life-Span and Specific Metabolic Rate in Primate Species. Proceedings of the National Academy of Sciences of the USA. 77(5):2777-81. May 1980 UCB, SA 1966.
Vernon MW and Sorkin EM. Piracetam. An Overview of its Pharmacological Properties and a Review of its Therapeutic Use in Senile Cognitive Disorders. Drugs & Aging, 1:17-35. 1991.
Wolthuis OL. Experiments with UCB 6215, A Drug which Enhances Acquisition in Rats: Its Effects Compared with Those of Metamphetamine. Eur. J. Pharm., 16:283-297. 1971.
The Reactions of Some Lanthanide Oxides with Liquid Lithium article from the Journal of the Less-Common Metals, 64 (1979) pp. 115-125,.
Low temperature phase transitions in RbDy(MoO.sub.4).sub.2 and Kdy(WO.sub.4).sub.2, article from Brief Communications, pp. 381-383, Sov. J. Low Temp. Phys. 4(6), Jun. 1978.
Preparation and Properties of Double Metaphosphates of Rare Earths and Lithium, N. N. Chudinova and N. V. Vinogradova, pp. 1706-1710, original article submitted Jun. 25, 1978.
Les Elements Des Terres Rares, Colloques Internationaux De Centre National De La Recherche Scientifique, Paris-Grenoble, 5-10 Mai 1969.
Rare Earth Research II, Proceedings of the Third Conference on Rare Earth Research, Apr. 21-24, 1963, Preparation and Structure of Some Mixed Lithium Rare Earth Compounds, Karl S. Vorres, pp. 147-151.
Condensed Matter, Coexistence of valence fluctuating and stable PR ions in Pr.sub.6 O.sub.11, E. Holland-Moritz, Original received Apr. 27, 1992, revised version Jun. 25, 1992, pp. 285-288.
Journal of Luminescence 1,2 (1970), Some Considerations on Rare-Earth Activated Phosphors, pp. 766-777,.
Publication, Electrical Conductivity and Oxygen Vacancy Mobility in CaO-DOPED Yitrium Oxide, original article submitted, Sep. 23, 1986, published Jan. 1989, S. Volchenkova and D.S. Zubankova, pp. 66-70.
Journal of Solid State Chemistry, Simultaneous Measurements of Oxygen pressure, Composition, and Electrical Conductivity in Praseodymium Oxides: II. Pr.sub.10 O.sub.18 and PrO.sub.2-x Phases, 1983, pp. 111-120.
Rare Earths No. 8, 1986. 3, The Rare Earth Society of Japan.
Journal of Solid State Chemitry 50, Simultaneous Measurements of Oxygen Pressure, Composition, and Electrical Conductivity of Praseodymium Oxides: I. Pr.sub.7 O.sub.12 and Pr.sub.9 O.sub.16 Phases, (1983), pp. 100-
LandOfFree
Therapeutic treatment for auditory function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment for auditory function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for auditory function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2136055